Live News Categoriesmarket

XBIO.O (XBIO.O) News

Follow XBIO.O (XBIO.O) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol XBIO.O Asset market Sector Markets 90 days 1 Updated Oct 15, 2026, 12:48 PM UTC Open live news feed

L Xenetic Reports First Patient Dosed in DNase — CAR T Combination Study for Large B — Cell Lymphoma Xenetic Biosciences announced the first patient was dosed in a study combining systemic DNase with CAR T-cell therapy for large B-cell lymphoma. The 12-patient study at Tel Aviv Sourasky University Medical Center marks t NEWS | Oct 15, 2026, 12:48 PM UTC